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Abstract
Background—Arsenic is associated with several adverse health outcomes, including some birth 
defects. Although diet is the predominant route of arsenic exposure in the United States (U.S.), 
limited data exist regarding pre-pregnancy dietary arsenic consumption among U.S. women.
Methods—Using data collected in the National Birth Defects Prevention Study (NBDPS), we 
estimated daily dietary arsenic consumption during the year before pregnancy for 10,886 mothers 
of nonmalformed control children delivered from 1997–2011. Responses to the NBDPS dietary 
assessment and food item estimates of total and inorganic arsenic were used to estimate 
consumption. Associations between total and inorganic arsenic consumption and selected maternal 
characteristics were estimated using multinomial logistic regression.
Results—Estimates of mean maternal total and inorganic dietary arsenic consumption were 14.9 
and 5.2 μg/day, respectively. Several positive and inverse associations with confidence intervals 
that excluded the null were observed. Comparing mothers in the middle or high total arsenic 
consumption tertiles to those in the low tertile, we observed positive associations (odds ratios = 
1.3–3.8) for maternal age (≥30 years), lower (0–8 years) or higher (>12 years) education, race/
ethnicity (non-Hispanic Black, Hispanic, other), and early pregnancy drinking with no binge 
episodes, and inverse associations (odds ratios = 0.4–0.8) for age (<25 years), body mass index 
(≥30.0 kg/m2), and early pregnancy smoking. Findings tended to be similar for inorganic arsenic 
consumption.
Conclusions—These contemporary estimates of pre-pregnancy dietary arsenic consumption 
among U.S. women show associations between both total and inorganic dietary arsenic 
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consumption and several maternal characteristics, improving characterization of the public health 
impact of this exposure.
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1 | INTRODUCTION
Arsenic is a naturally occurring element present in both inorganic and organic species. 
Inorganic arsenic is recognized as a greater threat to human health than organic arsenic 
(Hughes, Beck, Chen, Lewis, & Thomas, 2011) as evidenced by reports of positive 
associations with adverse health outcomes (reviewed in Abdul, Jayasinghe, Chandana, 
Jayasumana, & De Silva, 2015), including some birth defects (Jin et al., 2016). Most studies 
examined drinking water exposure. With low arsenic concentrations in finished drinking 
water throughout much of the United States (U.S.), however, diet is the predominant source 
of arsenic exposure (Kurzius-Spencer et al., 2014; Xue, Zartarian, Wang, Liu, & 
Georgopoulos, 2010). Currently, no consensus guidelines exist for tolerable dietary arsenic 
intake.
Inorganic arsenic contamination is found in rice, grains, vegetables, and fruits (reviewed in 
Agency for Toxic Substances and Disease Registry, 2007); organic arsenic contamination is 
found in shellfish (reviewed in Agency for Toxic Substances and Disease Registry, 2007). 
Contamination varies depending on water and soil composition (Yan-Chu, 1994) and can be 
affected by previous arsenical pesticide use (reviewed in Agency for Toxic Substances and 
Disease Registry, 2007). Despite diet being an important route of exposure and associations 
suggested between arsenic and birth defects, only one study with rather contemporary data 
(2006–2008) was identified that examined dietary arsenic consumption among U.S. 
reproductive-aged women. Using total arsenic (all forms) estimates from the U.S. Food and 
Drug Administration Total Diet Study (TDS) and median food consumption levels for 
different age–sex groups, investigators estimated dietary arsenic consumption among 
reproductive-aged women at approximately 0.16 μg/kg-body weight (bw)/day for total 
arsenic; applying various ratios of organic to inorganic arsenic in foods, estimates of 
inorganic arsenic consumption ranged from 0.03–0.08 μg/kg-bw/day (Jara & Winter, 2014).
Recently, we analyzed data collected in Iowa for the National Birth Defects Prevention 
Study (NBDPS) to investigate associations between multisource maternal arsenic exposure, 
including pre-pregnancy dietary arsenic consumption, and orofacial clefts in offspring (Suhl 
et al., 2018). We observed values for mothers of nonmalformed controls for total (0.16 
μg/kg-bw/day) and inorganic (0.07 μg/kg-bw/day) arsenic similar to those reported 
previously (Jara & Winter, 2014). The NBDPS is the largest U.S. population-based case-
control study of birth defects and enrolled children from 10 sites with estimated dates of 
delivery (EDDs) from 1997–2011 (Reefhuis et al., 2015). Mothers of control children who 
participated in the NBDPS were observed to be representative on several characteristics of 
U.S. mothers who delivered a liveborn child (Cogswell et al., 2009).
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Building on our Iowa study, we analyzed data for all NBDPS control mothers to estimate 
their dietary arsenic consumption during the year before pregnancy and associations with 
selected characteristics. Our findings provide additional insights into maternal pre-
pregnancy dietary arsenic consumption to better characterize the public health impact of this 
exposure.
2 | MATERIALS AND METHODS
2.1 | Study sample
NBDPS methods are detailed elsewhere (Reefhuis et al., 2015). NBDPS control children 
were a random sample of nonmalformed livebirths selected from hospital delivery logs or 
birth certificate files and delivered during the same timeframe and geographic catchment 
areas as case children. We restricted analyses to data reported by NBPDS control mothers as 
they may be more representative of the underlying distribution of pre-pregnancy dietary 
arsenic consumption among the general U.S. population than case mothers. The NBDPS 
protocol was approved by the institutional review board at the Centers for Disease Control 
and Prevention and each NBDPS site.
2.2 | Exposure assessment
NBDPS data collection included a telephone interview with case and control mothers 
administered 6 weeks to 24 months after their EDDs. The interview included a 58-item food 
frequency questionnaire (FFQ) adapted from the Willett FFQ (Willett, Reynolds, Cottrell-
Hoehner, Sampson, & Browne, 1987) to assess diet for the year before pregnancy. Dietary 
arsenic exposure methods are detailed elsewhere (Suhl et al., 2018). Briefly, each FFQ item 
was linked to all corresponding items in the TDS 1991–2005 (U.S. Food and Drug 
Administration, 2007) and 2006–2013 (U.S. Food and Drug Administration, 2017), and 
mean total arsenic concentrations were estimated for each FFQ item. The TDS assumes 
estimates below the limit of detection to be 0 μg/g; therefore, all such estimates were 
assumed to be 0 μg/g in our study. Because the NBDPS collected consumption estimates for 
the year before pregnancy, to retain the same TDS estimates for mothers with EDDs within 
the same calendar year, those with EDDs in 2006 were linked to 1991–2005 estimates, and 
those with EDDs in 2007 were linked to 2006–2013 estimates. For each mother who 
completed the FFQ, grams consumed of each FFQ item/day was estimated using their 
reported number of servings consumed/day and the item’s grams/serving, as reported in the 
U.S. Department of Agriculture Food Composition Database (U.S. Department of 
Agriculture, 2016). Grams consumed of each FFQ item/day were multiplied by the 
corresponding TDS mean arsenic concentration estimates to obtain the amount of arsenic 
consumed per FFQ item/day (μg/day). Total arsenic consumption (μg/day) was estimated by 
summing across all FFQ items. Inorganic arsenic consumption was estimated using the same 
approach but applying estimates reported in Schoof et al. (1999). Using maternal reported 
pre-pregnancy weight, we estimated μg/kg-bw/day for total and inorganic arsenic for 
comparison with previously reported estimates. Of the 58 FFQ items, TDS estimates for 
total arsenic were available for 55 items, and inorganic arsenic estimates were available for 
24 items.
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2.3 | Statistical analysis
We estimated mean, median, SD, and tertiles of exposure (in μg/day and μg/kg-bw/day) for 
maternal pre-pregnancy total and inorganic dietary arsenic consumption. Mothers who 
reported total energy intakes of <500 or >5,000 calories/day were excluded from analyses. 
Crude odds ratios and 95% confidence intervals were estimated using multinomial logistic 
regression to identify associations between selected maternal characteristics and total and 
inorganic dietary arsenic consumption; the lowest tertile of consumption was used as the 
comparator outcome category. Characteristics examined were maternal age and education at 
delivery, race/ethnicity, pre-pregnancy body mass index, NBDPS site, and early pregnancy 
(one month before through the third month of pregnancy) alcohol use and cigarette smoke 
exposure. We examined dietary arsenic exposure independent of drinking water exposure 
due to challenges we encountered in linking maternal residence to water arsenic 
measurements in our Iowa study, the generally low arsenic concentrations in U.S. finished 
drinking water, and the low proportion (8%) of NBDPS mothers that reported using well 
water. Analyses were conducted using SAS v. 9.4 (SAS Institute Inc., 2013).
3 | RESULTS
Overall, 11,829 control mothers participated in the NBDPS with 11,157 providing responses 
to each FFQ item. Of these 11,157 mothers, 271 consumed <500 or >5,000 calories/day and 
were excluded from analyses, leaving 10,886 mothers. Using FFQ data reported by these 
10,886 mothers, we estimated mean maternal pre-pregnancy total dietary arsenic 
consumption per day at 14.9 μg/day (SD = 22.4; median = 8.2; range = 0.1–699.4; tertiles: 
low = <4.5, middle = 4.5–15.4, high = ≥15.4 μg/ day) and inorganic dietary arsenic 
consumption at 5.2 μg/day (SD = 4.0; median = 4.2; range = 0.1–55.3; tertiles: low = <3.2, 
middle = 3.2–5.5, high = ≥5.5 μg/ day). The respective estimates for mean total and 
inorganic dietary arsenic consumption in μg/kg-bw/day were 0.23 and 0.08.
We observed several positive and inverse associations between selected maternal 
characteristics and total dietary arsenic consumption, for which most confidence intervals 
excluded the null. Mothers in the middle and high tertiles, compared to those in the low 
tertile, were more likely to be older (≥30 years), have lower (0–8 years) or higher (>12 
years) education, be of non-Hispanic Black, Hispanic, or other race/ethnicity, and drink 
alcohol with no binge events during early pregnancy (odds ratios = 1.3–3.8); these mothers 
were less likely to be younger (<25 years), obese (≥30 kg/m2), or exposed to cigarette smoke 
(active smoking only, active and passive smoking) early in pregnancy (odds ratios = 0.4–0.8) 
(Table 1). Additionally, mostly positive associations were observed for NBDPS site, using 
Iowa as the reference. Associations observed for inorganic dietary arsenic consumption were 
similar in direction as those for total arsenic, except for reduced associations for non-
Hispanic Black mothers in the middle and high tertiles and reduced associations for mothers 
who reported early pregnancy alcohol use (Table 2). Results examining tertiles in μg/kg-
bw/day were generally similar in direction to those examining tertiles in μg/day (data not 
shown).
Suhl et al. Page 4
Birth Defects Res. Author manuscript; available in PMC 2020 March 27.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
4 | DISCUSSION
Among NBDPS control mothers, we estimated mean pre-pregnancy daily consumption of 
total and inorganic arsenic at 14.9 μg/day (0.23 μg/kg-bw/day) and 5.2 μg/day (0.08 μg/kg-
bw/day), respectively. Our estimates for total and inorganic arsenic were higher than (total) 
or similar to (inorganic) those reported for U.S. reproductive-aged women reported during a 
contemporaneous time period (Jara & Winter, 2014). Compared to earlier reported estimates 
(1981–1996), our estimates were lower for total arsenic (reviewed in Agency for Toxic 
Substances and Disease Registry, 2007; Gunderson, 1988) but similar for inorganic arsenic 
(reviewed in Agency for Toxic Substances and Disease Registry, 2007). We identified 
several positive and inverse associations for selected maternal characteristics when 
comparing middle and high levels of total and inorganic arsenic consumption to the 
respective low levels. These novel data can help guide strategies to reduce pre-pregnancy 
dietary intake of arsenic among U.S. reproductive-aged women.
The previous studies and our current study used total arsenic concentration estimates 
provided by the TDS. Total arsenic is a composite measure of several arsenic species. 
Examination of total arsenic may mask the effects of harmful arsenic species, as arsenic 
metabolism and its associated toxicity varies depending on the species. Inorganic arsenic is 
metabolized into forms that are considered to be highly toxic (Thomas, Styblo, & Lin, 
2001), whereas organic arsenic is excreted virtually unchanged in humans (Taylor et al., 
2017). Although some foods (e.g., seafoods) are high in total arsenic, it is primarily organic, 
which is less harmful than inorganic arsenic (reviewed in Agency for Toxic Substances and 
Disease Registry, 2007).
Available information on inorganic arsenic in food is sparse, limiting dietary inorganic 
arsenic consumption estimation. A single study reported inorganic arsenic concentration 
estimates in food (Schoof et al., 1999); however, foods only were collected from two 
communities in Texas in 1997. These estimated inorganic arsenic concentrations may not 
accurately reflect concentrations in foods consumed throughout the U.S. due to the use of 
global food sources in the U.S. (Pirog, Van Pelt, Enshayan, & Cook, 2001) and the 
variability in concentrations in water used for cooking, which can influence the inorganic 
arsenic content in foods (Bae et al., 2002). These limitations underscore the need for 
improved estimates of inorganic arsenic content in foods.
Our study was strengthened by examining associations between maternal characteristics and 
pre-pregnancy dietary arsenic consumption among a nationally representative sample of U.S. 
women who delivered a liveborn child, which were not examined in previous studies, as well 
the use of individual FFQ reports and inorganic arsenic estimates for individual food items. 
Conversely, our study may have been limited by reliance on retrospective recall of pre-
pregnancy diet; however, dietary recall among pregnant and nonpregnant women is similar 
(Ramage et al., 2015). Another limitation was that FFQ items for common sources of dietary 
arsenic, such as shrimp (organic) and rice (inorganic) (reviewed in Agency for Toxic 
Substances and Disease Registry, 2007), were omitted (shrimp) or grouped with other food 
items (rice). Also, total or inorganic arsenic estimates were not available for all FFQ items, 
underestimating dietary arsenic consumption. Additionally, wine may contain inorganic 
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arsenic (Wilson, 2015), but its consumption was not queried separately. Finally, with the 
present data, it is difficult to meaningfully explore differences observed in arsenic 
consumption across NBDPS sites.
In summary, we estimated pre-pregnancy dietary arsenic consumption among a more 
contemporary, nationally representative sample of U.S. women who delivered a liveborn 
child. Associations between dietary arsenic consumption and several maternal characteristics 
also were observed. Currently, no consensus guidelines exist for dietary arsenic intake, and 
the Joint Food and Agriculture Organization/World Health Organization Expert Committee 
on Food Additives recently withdrew their provisional tolerable arsenic intake of 2.1 μg/kg-
bw/day, as it was considered not protective of human health (Joint FAO/WHO Expert 
Committee on Food Additives, 2011). Similarly, the U.S. Environmental Protection Agency 
reference dose (daily dose likely to be without an appreciable risk of noncancer effects) for 
inorganic arsenic is 0.3 μg/kg-bw/day (reviewed in Agency for Toxic Substances and 
Disease Registry, 2007); however, this estimate was based on dermal and cardiovascular 
effects. As such, it is difficult to meaningfully interpret how reported levels of pre-pregnancy 
dietary arsenic consumption impact pregnancy outcomes. Additional research is needed to 
improve estimates of inorganic arsenic content in foods and better characterize arsenic 
consumption among this population, as well as its contribution to the development of birth 
defects.
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